2型炎症性呼吸道疾病的管理:一个中国专家的共识 [2024]
Nan Jia1, Meiling Jin2, Yun Liu3
1Department of Allergy and Clinical Immunology, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
生物治疗为2型 (T2) 炎症性呼吸道疾病提供了新的希望. 这种共识为选择和启动T2向治疗提供了指导,以获得更好的患者结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型 (T2) 炎症性呼吸道疾病的特征是T2气道炎症和肺.
- 针对T2炎症的生物治疗正在改变护理,但存在治疗选择挑战.
- 困难包括确定最佳患者人群,治疗时间和特定的生物药物.
研究的目的:
- 制定关于T2炎症性呼吸道疾病管理的共识报告.
- 为使用针对T2炎症的生物疗法提供基于证据的建议.
- 为中国的临床医生提供有效诊断和管理的指导.
主要方法:
- 在PubMed (2014-2024) 对T2炎症性呼吸道疾病进行了全面的文献搜索.
- 使用GRADE系统评估证据质量和建议.
- 通过两轮匿名投票,专家小组达成共识.
主要成果:
- 审查了370项研究结果和临床数据.
- 专家小组讨论涵盖了病原,T2炎症评估和生物治疗.
- 形成了一个包含可行的建议的共识报告.
结论:
- 共识报告详细介绍了T2炎症性呼吸道疾病和并发性疾病的发病,评估和管理.
- 它强调了针对T2炎症的生物疗法.
- 本指南旨在加强诊断和管理这些疾病的临床决策.
更多相关视频
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
